Shots: BioNTech and Fosun collaborated to supply 10M doses of their BNT162 mRNA-based vaccine candidate against COVID-19 to Hong Kong SAR and Macao SAR, once approved Fosun Pharma has signed […]readmore
Tags : Hong Kong
Biosimilars
Mundipharma Collaborates with Samsung Bioepis to Commercialize Multiple Biosimilar Candidates
Shots: Mundipharma to get exclusive commercialization rights for Samsung Bioepis’ first-wave biosimilar candidates in Taiwan and Hong Kong while Samsung Bioepis will remain MAH, responsible for the development, regulatory and […]readmore
Shots: Mithra to get up front, sales milestones, royalties and recurring revenues based on Minimal Annual Quantities (MAQ) and will manufacture Estelle at its Contract Development and Manufacturing Organization facility […]readmore
Shots: The ECG app on Apple Watch Series 4 is evaluated in 600 patients resulted in 98.3% sensitivity in classifying AFib, 99.6% specificity in classifying sinus rhythm, 87.8% of recordings […]readmore